[HTML][HTML] Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium …

K Marwa, A Kapesa, V Baraka, E Konje, B Kidenya… - PloS one, 2022 - journals.plos.org
Background Sub-Saharan Africa has the highest burden of malaria in the world. Artemisinin-
based combination therapies (ACTs) have been the cornerstone in the efforts to reduce the …

[HTML][HTML] Biology and epidemiology of Plasmodium falciparum and Plasmodium vivax gametocyte carriage: implication for malaria control and elimination

A Alemayehu - Parasite Epidemiology and Control, 2023 - Elsevier
Malaria is among the leading public health problems worldwide. Female anopheles
mosquito orchestrates the transmission of malaria by taking gametocytes and introducing …

[HTML][HTML] Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia

M Teklemariam, A Assefa, M Kassa, H Mohammed… - Plos one, 2017 - journals.plos.org
Malaria, particularly due to Plasmodium falciparum, remains a major public health threat in
Ethiopia. Artemether-lumefantine (AL) has been the first-line antimalarial drug against …

[HTML][HTML] Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller …

AM Dorkenoo, D Yehadji, YM Agbo, Y Layibo… - Malaria journal, 2016 - Springer
Abstract Background Since 2005, the Togo National Malaria Control Programme has
recommended two different formulations of artemisinin-based combination therapy (ACT) …

[HTML][HTML] Detection of foci of residual malaria transmission through reactive case detection in Ethiopia

E Zemene, C Koepfli, A Tiruneh, AK Yeshiwondim… - Malaria journal, 2018 - Springer
Background Sub-microscopic and asymptomatic infections could be bottlenecks to malaria
elimination efforts in Ethiopia. This study determined the prevalence of malaria, and …

[HTML][HTML] Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia

A Abamecha, D Yilma, W Addisu, H El-Abid, A Ibenthal… - Malaria Journal, 2020 - Springer
Background The efficacy of artemether-lumefantrine (AL) for treatment of uncomplicated
Plasmodium falciparum malaria in south-western Ethiopia is poorly documented. Regular …

Therapeutic Efficacy of Artemether‐Lumefantrine (Coartem®) for the Treatment of Uncomplicated Falciparum Malaria in Africa: A Systematic Review

A Derbie, D Mekonnen, M Adugna… - Journal of …, 2020 - Wiley Online Library
Background. Africa still bears the largest burden of malaria as the majority of infections in the
continent are caused by P. falciparum. Artemether‐lumefantrine (AL, Coartem®) is the most …

[HTML][HTML] Anti-malarial treatment outcomes in Ethiopia: a systematic review and meta-analysis

EA Gebreyohannes, AS Bhagavathula, MA Seid… - Malaria journal, 2017 - Springer
Background Ethiopia is among countries with a high malaria burden. There are several
studies that assessed the efficacy of anti-malarial agents in the country and this systematic …

[HTML][HTML] Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India

PK Bharti, MM Shukla, P Ringwald, S Krishna… - Malaria journal, 2016 - Springer
Background Anti-malarial drug resistance continues to be a leading threat to malaria control
efforts and calls for continued monitoring of waning efficacy of artemisinin-based …

[HTML][HTML] Combining long-lasting insecticidal nets and indoor residual spraying for malaria prevention in Ethiopia: study protocol for a cluster randomized controlled trial

W Deressa, E Loha, M Balkew, A Hailu, T Gari… - Trials, 2016 - Springer
Background Long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) are
the main malaria prevention interventions in Ethiopia. There is conflicting evidence that the …